← Back to Search

Behavioral Intervention

Educational Intervention for Childhood Obesity

N/A
Waitlist Available
Led By Kerry Mychaliksa, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial will study a standardized protocol to manage childhood obesity, to help avoid its health complications and prevent it from continuing into adulthood.

Who is the study for?
This trial is for children and teens aged 2-17 years who are overweight or obese (BMI at or above the 85th percentile) visiting a pediatric clinic in Royal Oak, Michigan. It's not for those under 2, over 17, pregnant, or with decision-making impairments.Check my eligibility
What is being tested?
The study tests a low-resource approach to manage pediatric obesity in primary care using age-appropriate educational materials and bi-weekly check-ins to help achieve healthy lifestyle goals. The main measure of success will be changes in BMI percentile over six months.See study design
What are the potential side effects?
Since this intervention involves education and lifestyle modification rather than medication, there are no direct side effects like you'd expect from drugs. However, participants may experience stress or frustration related to lifestyle changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline body mass index (BMI) percentile at 24 weeks
Secondary outcome measures
Adherence to follow-up scheduling
Change in diastolic blood pressure percentile at 24 weeks
Change in serum alanine transaminase (ALT) at 24 weeks
+18 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioral interventionExperimental Treatment1 Intervention
Behavioral intervention for healthy lifestyle goals, four analysis groups divided by age (2-4, 5-8, 9-11, 12-17)

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
149 Previous Clinical Trials
112,809 Total Patients Enrolled
Kerry Mychaliksa, MDPrincipal InvestigatorWilliam Beaumont Hospitals

Media Library

Age-specific educational materials and monitoring (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05622981 — N/A
Eating Disorders Research Study Groups: Behavioral intervention
Eating Disorders Clinical Trial 2023: Age-specific educational materials and monitoring Highlights & Side Effects. Trial Name: NCT05622981 — N/A
Age-specific educational materials and monitoring (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05622981 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this research opportunity apply?

"This clinical trial calls for 500 pediatric participants with obesity. The ideal candidates are those visiting the Beaumont Pediatric Outpatient Clinic in Royal Oak, Michigan who range from 2 to 17 years of age and have a BMI at or above the 85th percentile."

Answered by AI

Would this research endeavor permit octogenarians to partake in the experiment?

"This clinical trial is seeking patients between 2 and 17 years of age."

Answered by AI

Is there an opportunity for new participants in this clinical trial?

"As evidenced on clinicaltrials.gov, this particular trial is not presently recruiting participants; the original posting date was January 1st 2023 while the last update occurred November 21st 2022. Nevertheless, 1022 other trials remain in search of suitable candidates across a variety of medical domains."

Answered by AI
~24 spots leftby Apr 2025